ABBV vs AXL · P/E 81, rev $16.99B vs P/E 25, rev $6.12B
AbbVie Inc (ABBV) versus American Axle & Manufacturing (AXL) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
American Axle & Manufacturing (AXL) is a auto parts company listed on US.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported AXL revenue for 2024-12-31 was $6.12B. Net income was $35.0M. Revenue was up 0.7% from 2023-12-31 to 2024-12-31. AXL currently screens at market cap $529.2M and trailing P/E 24.8.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. AXL currently screens at market cap $529.2M and trailing P/E 24.8.
Not investment advice. Open the ABBV and AXL stock pages for the full models.
Not investment advice.